阿尔特米斯及其在癌症中的作用
Armen Parsyan1, Vasudeva Bhat2, Harjot Athwal3
1Department of Anatomy and Cell Biology, Western University, London, ON, N6A 3K7, Canada; Verspeeten Family Cancer Centre, London Health Sciences Centre, London, ON, N6A 5W9, Canada; Department of Oncology, Western University, London, ON, N6A 3K7, Canada; Department of Surgery, St Joseph's Health Care and London Health Sciences Centre, Western University, London, ON, N6A 4V2, Canada.
Translational oncology
|November 9, 2024
概括
阿尔特米斯是一种DNA修复核酶,对癌症的发展和治疗耐药性至关重要. 向阿尔特米斯提供了改善癌症预后和新治疗策略的潜力.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 阿尔特米斯是DNA双链断裂修复和V(D) J重组中的关键核酶.
- 它的突变导致严重的综合免疫缺陷和辐射敏感性.
- 甲状腺的放松管制与癌症的进展和治疗耐药性有关.
研究的目的:
- 审查阿尔特米斯在DNA修复和瘤发生中的功能.
- 探索阿特米斯在各种恶性瘤中的作用.
- 评估Artemis作为瘤学中的生物标志物和治疗点.
主要方法:
- 关于Artemis功能和临床相关性的文献综述.
- 综合关于阿尔特米斯在癌症中的作用的信息.
- 分析阿尔特米斯作为药物开发目标的分析.
主要成果:
- 阿尔特米斯参与DNA修复和V(D) J重组.
- 阿尔特米斯的放松管制与不良的瘤结果有关.
- 阿尔特米斯会影响对放射治疗,化疗和向治疗的敏感性.
结论:
- 阿尔特米斯是癌症预后和治疗的有希望的候选人.
- 它在调节对DNA损伤剂敏感性的作用使其成为一个可行的药物标.
- 目前正在调查针对Artemis的现有和新型化合物.
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Cancer
48.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.1K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328


